Global Pharma and China Biotech Meet at ChinaBio® Partnering Forum
in Shanghai
SHANGHAI & CARLSBAD, Calif. July 2, 2009
—The ChinaBio® Partnering
Forum, held in Shanghai, was by all measures an unqualified success. Co-produced by ChinaBio® LLC and EBD Group, the ChinaBio® Partnering Forum was the first biotech/pharma partnering conference held in
China, attracting 486 attendees from 274 companies and 29 countries.
Greg Scott, President and Founder of ChinaBio LLC, and Carola Schropp, President
and Founder of EBD Group, confirmed that the event significantly exceeded the original projections of 300 attendees. "Interest was high from both sides of the biopharma industry," said Scott, "with the global pharma looking for new drug candidates and development platforms in China, and China`s biotech companies and researchers seeking partnerships to develop some highly interesting novel technologies created in China."
"Most of the global pharmaceutical companies attended the event, including Bayer, AstraZeneca, Merck, Roche, and Pfizer, and all of them were actively seeking partnerships," said Carola Schropp, President of EBD Group.
"More than 570 one-to-one meetings were scheduled during the Partnering Forum, which is a very strong number for a first time event," added Schropp, whose firm has helped to generate over 24,000 one-to-one meetings over the past year through some of the largest and most productive partnering events for the life science industry such as BIO-Europe, BIO-Europe Spring® and BioPharm America.
Creating cross-border partnerships was the primary theme of the ChinaBio Partnering Forum, which took advantage of EBD Group`s web-based partneringONE system to facilitate one-to-one meetings between attendees at the event. EBD Group pioneered automated partnering, and the attendees, many of them first time users of partneringONE, reported that the system was easy to use and very effective at identifying potential partners they wished to meet.
"We had over 20 meetings during the ChinaBio Partnering Forum," said Yuwen Liu, General Manager of BioBay in Suzhou, which is the fastest growing life science park in China. "We have attended other major partnering events in the U.S., and the ChinaBio Partnering Forum was very well organized and the attendees were of very high caliber. We met several companies we expect to collaborate with in the near future."
The ChinaBio Partnering Forum was the seventh event organized by ChinaBio LLC in China and the first event EBD Group held in Asia. Scott said, "We felt that bringing together our credibility with China biopharma with EBD Group`s expertise in global life science partnering would result in a highly successful event, and that`s exactly what happened."
Next year`s ChinaBio Partnering Forum is scheduled to be held in Suzhou at the new Cold Spring Harbor Conference Center on June 23-24, 2010. EBD Group and ChinaBio LLC are also organizing several other joint events, the next being ChinaBio® Day on September 15, 2009, which is a pre-conference to EBD Group`s BioPharm America in San Francisco.
About ChinaBio® LLC
Since its founding in January, 2007, ChinaBio® LLC has
rapidly launched a number of successful initiatives connecting
China biotech with the world. With offices in Shanghai,
Silicon Valley and San Diego, ChinaBio®’s activities include:
- Conferences: Organizer of the premier life science
investment and partnering forums in China, which have helped early stage China companies raise over USD
100 million to date.
- Consulting: : Helping global life science companies, entrepreneurs and investors
understand the China life science market, create a China strategy, and identify
novel technologies and partners.
- Accelerator: Assisting early stage China companies
to raise over USD 60 million to date.
- Information: Developing in-depth market intelligence and databases on novel
technology development, clinical trials, and investment and partnering activity
in China.
- ChinaBio® Today: Publishing online and email newsletters
focusing exclusively on China’s life science industry.
About EBD Group
EBD Group is the leading partnering firm for the global
life science industry. Since 1993, biotech, pharma and
medical device companies have leveraged EBD Group’s partnering
conferences, technology and services to identify business
opportunities and develop strategic relationships essential
to their success.
EBD Group’s conferences are run with the support of leading
corporations and international trade associations and
include:
- BIO-Europe and BIO-Europe Spring®, the world's largest
stand-alone life science partnering conferences, supported
by the Biotechnology Industry Organization (BIO)
- BioPharm America™, EBD Group’s North American partnering
event
- EuroMedtech™, EBD Group’s new partnering event for
the innovative medical technology industry
- BioEquity Europe, the investor conference co-organized
with BioCentury Publications and BIO
- ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering
conference in China co-produced with ChinaBio LLC.
EBD Group’s sophisticated web-based partnering service,
partneringONE™, is used as the partnering engine at numerous
third-party events around the world. Outside of the conference
format, EBD Group’s consultants provide hands-on assistance
for firms seeking to in- or out-license products and technologies.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.
Contact:
In China
Jean Meng
ChinaBio LLC
China: +86 5137 0751
USA: +1 858 926 4566
jmeng@chinabiollc.com
In the USA
Constantine Theodoropulos
EBD Group
USA: +1 617 292 7319
ctheodoropulos@ebdgroup.com
